APA (7th ed.) Citation

Guan, W., Wang, L., & Peng, X. (2022). Targeting Bruton's tyrosine kinase in vitreoretinal lymphoma: An open-label, prospective, single-center, phase 2 study. Experimental Hematology & Oncology, 11(1), 1. https://doi.org/10.1186/s40164-022-00354-2

Chicago Style (17th ed.) Citation

Guan, Wenxue, Liang Wang, and Xiaoyan Peng. "Targeting Bruton's Tyrosine Kinase in Vitreoretinal Lymphoma: An Open-label, Prospective, Single-center, Phase 2 Study." Experimental Hematology & Oncology 11, no. 1 (2022): 1. https://doi.org/10.1186/s40164-022-00354-2.

MLA (9th ed.) Citation

Guan, Wenxue, et al. "Targeting Bruton's Tyrosine Kinase in Vitreoretinal Lymphoma: An Open-label, Prospective, Single-center, Phase 2 Study." Experimental Hematology & Oncology, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1186/s40164-022-00354-2.